Please use this identifier to cite or link to this item:
|Title:||Bioinspired cell-derived nanovesicles versus exosomes as drug delivery systems : a cost-effective alternative||Authors:||Goh, Wei Jiang
Ong, Wei Yi
Alexandra, Alvarez Fernandez
Schiffelers, Raymond M.
|Keywords:||Cell Derived Nanovesicles
Drug Delivery Systems
|Issue Date:||2017||Source:||Goh, W. J., Zou, S., Ong, W. Y., Torta, F., Alexandra, A. F., Schiffelers, R. M., et al. (2017). Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative. Scientific Reports, 7(1), 14322-.||Series/Report no.:||Scientific Reports||Abstract:||Cell Derived Nanovesicles (CDNs) have been developed from the rapidly expanding field of exosomes, representing a class of bioinspired Drug Delivery Systems (DDS). However, translation to clinical applications is limited by the low yield and multi-step approach in isolating naturally secreted exosomes. Here, we show the first demonstration of a simple and rapid production method of CDNs using spin cups via a cell shearing approach, which offers clear advantages in terms of yield and cost-effectiveness over both traditional exosomes isolation, and also existing CDNs fabrication techniques. The CDNs obtained were of a higher protein yield and showed similarities in terms of physical characterization, protein and lipid analysis to both exosomes and CDNs previously reported in the literature. In addition, we investigated the mechanisms of cellular uptake of CDNs in vitro and their biodistribution in an in vivo mouse tumour model. Colocalization of the CDNs at the tumour site in a cancer mouse model was demonstrated, highlighting the potential for CDNs as anti-cancer strategy. Taken together, the results suggest that CDNs could provide a cost-effective alternative to exosomes as an ideal drug nanocarrier.||URI:||https://hdl.handle.net/10356/89524
|ISSN:||2045-2322||DOI:||10.1038/s41598-017-14725-x||Rights:||© 2017 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Te images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||MSE Journal Articles|
Files in This Item:
|Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems a Cost-Effective Alternative.pdf||3.81 MB||Adobe PDF|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.